Oliveira Claudia P, de Lima Sanches Priscila, de Abreu-Silva Erlon Oliveira, Marcadenti Aline
Department of Gastroenterology, School of Medicine, University of Sao Paulo (USP), 255 Dr. Enéas de Carvalho Aguiar Avenue, Cerqueira César, 05403-900 Sao Paulo, SP, Brazil.
Postgraduate Program in Nutrition, Federal University of Sao Paulo (UNIFESP), 630 Marselhesa Street, Vila Clementino, 04020-060 Sao Paulo, SP, Brazil.
J Diabetes Res. 2016;2016:4597246. doi: 10.1155/2016/4597246. Epub 2015 Dec 7.
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and it is associated with other medical conditions such as diabetes mellitus, metabolic syndrome, and obesity. The mechanisms of the underlying disease development and progression are not completely established and there is no consensus concerning the pharmacological treatment. In the gold standard treatment for NAFLD weight loss, dietary therapy, and physical activity are included. However, little scientific evidence is available on diet and/or physical activity and NAFLD specifically. Many dietary approaches such as Mediterranean and DASH diet are used for treatment of other cardiometabolic risk factors such as insulin resistance and type-2 diabetes mellitus (T2DM), but on the basis of its components their role in NAFLD has been discussed. In this review, the implications of current dietary and exercise approaches, including Brazilian and other guidelines, are discussed, with a focus on determining the optimal nonpharmacological treatment to prescribe for NAFLD.
非酒精性脂肪性肝病(NAFLD)是全球最常见的肝脏疾病,它与其他病症相关,如糖尿病、代谢综合征和肥胖症。潜在疾病发展和进展的机制尚未完全明确,关于药物治疗也没有达成共识。NAFLD的金标准治疗包括减肥、饮食疗法和体育活动。然而,关于饮食和/或体育活动与NAFLD的具体关系,科学证据很少。许多饮食方法,如地中海饮食和得舒饮食(DASH饮食),被用于治疗其他心血管代谢风险因素,如胰岛素抵抗和2型糖尿病(T2DM),但根据其成分,它们在NAFLD中的作用一直存在争议。在这篇综述中,我们讨论了当前饮食和运动方法的影响,包括巴西和其他指南,重点是确定针对NAFLD的最佳非药物治疗方案。